Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer
- PMID: 22833829
- PMCID: PMC3378213
- DOI: 10.3978/j.issn.2072-1439.2012.03.02
Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer
Conflict of interest statement
No potential conflict of interest.
References
-
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300 - PubMed
-
- Crinó L, Weder W, van Meerbeeck J, Felip E, ESMO Guidelines Working Group. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:v103-v115 - PubMed
-
- Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26:3552-3559 - PubMed
-
- Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol. 2008;26:5043-5051 - PMC - PubMed
LinkOut - more resources
Full Text Sources